1.Burg ED，Remillard CV，Yuan JX.，et al..Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis:pharmacotherapeutic implications.British journal of pharmacology，2008，153（S1）:S99-S111.

2.Lopes，A.A.Pathophysiological basis for anticoagulant and antithrombotic therapy in pulmonary hypertension.Cardiovascular ＆Hematological Agents in Medicinal Chemistry，2006，4（1）:53-59.

3.Schermuly RT，Ghofrani HA，Wilkins MR，et al.Mechanisms of disease:pulmonary arterial hypertension.Nature Reviews Cardiology，2011，8（8）:443-455.

4.Larissa A.Shimoda，Steven S.Laurie.Vascular remodeling in pulmonary hypertension.Journal of Molecular Medicine，2013，91（3）:297-309.

5.Tuder RM，Marecki JC，Richter A，et al.Pathology of pulmonary hypertension.Clin Chest Med，2007，28 （1）:23-42.

6.Wilkins，MR.Pulmonary hypertension:the science behind the disease spectrum.European Respiratory Review，2012，21（123）:19-26.

7.Soubrier F，Chung WK，Machado R，et al.Genetics and genomics of pulmonary arterial hypertension.Journal of American College of Cardiology，2013，62（25Suppl）:D13-D21.

8.Kerstjens-Frederikse WS，Bongers EM，Roofthooft MT，et al.TBX4mutations（small patella syndrome）are associated with childhood-onset pulmonary arterial hypertension.Journal of medical genetics，2013，50 （8）:500-506.

9.Courboulin A，Paulin R，Giguère NJ，et al.Role for miR-204in human pulmonary arterial hypertension.The journal of experimental medicine，2011，208（3）:535-548.